Matrix contraction by dermal fibroblasts requires transforming growth Factor-ß /activin-linked kinase 5, heparan sulfate-containing proteoglycans, and MEK/ERK: insights into pathological scarring in chronic fibrotic disease
Chen, Y., Shi-Wen, X., van Beek, J., Kennedy, L., McLeod, M., Renzoni, E.A., Bou-Gharios, G., Wilcox-Adelman, S., Goetinck, P.F., Eastwood, M., Black, C.M., Abraham, D.J. and Leask, A. 2005. Matrix contraction by dermal fibroblasts requires transforming growth Factor-ß /activin-linked kinase 5, heparan sulfate-containing proteoglycans, and MEK/ERK: insights into pathological scarring in chronic fibrotic disease. American Journal of Pathology. 167 (6), pp. 1699-1711.